FatenNAberraMD

PubMed

• The Impact of Introducing Patient-Reported Inflammatory Bowel Disease Symptoms via Electronic Survey on Clinic Visit Length, Patient and Provider Satisfaction, and the...
  Unmesha Roy Paladhi, Ali H Harb, Scott G. Daniel, Ghadeer K. Dawwas, Erin M Schnellinger, Colin Wollack, Faten Aberra, Meenakshi Bewtra, Jesse Green, Jan-Michael A Kla...> ;Inflammatory Bowel Diseases. 2021 Jan 16
• Indeterminate QuantiFERON-TB Gold Increases Likelihood of Inflammatory Bowel Disease Treatment Delay and Hospitalization.
  Ravy K. Vajravelu, Mark T. Osterman, Faten Aberra, Jason Roy, Gary R. Lichtenstein, Ronac Mamtani, David S. Goldberg, James D. Lewis, Frank I. Scott> ;Inflammatory Bowel Diseases. 2018 Jan 1
• 1 citations
  Measurement of Inflammatory Bowel Disease Symptoms: Reliability of an Abbreviated Approach to Data Collection.
  Maria Paula Henao, Meenakshi Bewtra, Mark T. Osterman, Faten Aberra, Frank I. Scott, Gary R. Lichtenstein, Jennifer L. Kraschnewski, James D. Lewis> ;Inflammatory Bowel Diseases. 2015 Apr 1
• Can Colonoscopy Reduce the Risk of Colon Cancer and Mortality in Patients With Inflammatory Bowel Disease?
  Aberra, F. N., Osterman, M. T., Lewis, J. D.> ;Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association. 2015 Mar 1
• 22 citations
  Mesalamine dose escalation reduces fecal calprotectin in patients with quiescent ulcerative colitis.
  Osterman, M. T., Aberra, F. N., Cross, R. K., Liakos, S., McCabe, R., Shafran, I., Wolf, D. C., Hardi, R., Nessel, L., Brensinger, C. M., Gilroy, E., Lewis, J. D.> ;Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association. 2014 May 6
• Impact of JC virus antibody testing in patients with Crohn's disease with loss of response to infliximab: a Markov model.
  Frank I. Scott, Mark T. Osterman, Ryan A. McConnell, Monica Lorusso, Faten Aberra, Caroline Kerner, Gary R. Lichtenstein, James D. Lewis> ;Inflammatory Bowel Diseases. 2013 Nov 1
• Teduglutide in Crohn's disease
  Wojciech Blonski, Anna M. Buchner, Faten Aberra, Gary R. Lichtenstein> ;Expert Opinion on Biological Therapy. 2013 Jul 9
• Antiviral effects of autologous CD4 T cells genetically modified with a conditionally replicating lentiviral vector expressing long antisense to HIV.
  Pablo Tebas, David K. Stein, Gwendolyn Binder-Scholl, Rithun Mukherjee, Troy Brady, Tessio Rebello, Laurent Humeau, Michael Kalos, Emmanouil Papasavvas, Luis J. Montan...> ;Blood. 2013 Feb 28
• Papillary thyroid cancer and inflammatory bowel disease: is there a relationship?
  Irene Sonu, Wojciech Blonski, Ming Valerie Lin, James D. Lewis, Faten Aberra, Gary R. Lichtenstein> ;World Journal of Gastroenterology. 2013 Feb 21
• Vitamin D Deficiency Is Associated with Ulcerative Colitis Disease Activity
  Stacey Blanck, Faten Aberra> ;Digestive Diseases and Sciences. 2013 Jan 19
• As in the chicken or the egg: stress or inflammatory bowel disease?
  Faten Aberra, James D. Lewis> ;Clinical Gastroenterology and Hepatology. 2013 Jan 1
• VSL#3 for ulcerative colitis: growing evidence?
  Frank I. Scott, Faten Aberra> ;Gastroenterology. 2011 May 1
• Disruption of Intestinal CD4+ T Cell Homeostasis Is a Key Marker of Systemic CD4+ T Cell Activation in HIV-Infected Individuals
  Shari N. Gordon, Barbara Cervasi, Pamela M. Odorizzi, Randee Silverman, Faten Aberra, Gregory G. Ginsberg, Jacob D. Estes, Mirko Paiardini, Ian Frank, Guido Silvestri> ;Journal of Immunology. 2010 Nov 1
• Unintended effects of a computerized physician order entry nearly hard-stop alert to prevent a drug interaction: a randomized controlled trial.
  Brian L. Strom, Rita Schinnar, Faten Aberra, Warren B. Bilker, Sean Hennessy, Charles E. Leonard, Eric A. Pifer> ;JAMA Internal Medicine. 2010 Sep 27
• Is it time for dosing anti-TNF antibody therapy by serum level?
  Caroline Kerner, Faten Aberra> ;Gastroenterology. 2010 Jul 1
• Prescribing an antibiotic? Do not forget the probiotic.
  Vrabie, R., Aberra, F. N.> ;Gastroenterology. 2009 Oct 1
• 4 citations
  Comparison of interferon-gamma release assay versus tuberculin skin test for tuberculosis screening in inflammatory bowel disease.
  Aberra, F. N.> ;Gastroenterology. 2009 Feb 24
• Clinical Challenges and Images in GI
  Meenakshi Bewtra, Ashlie N. Burkart, Faten Aberra> ;Gastroenterology. 2009 Feb 1
• Use of the noninvasive components of the mayo score to assess clinical response in Ulcerative Colitis
  James D. Lewis, Shaokun Chuai, Lisa Nessel, Gary R. Lichtenstein, Faten Aberra, Jonas H. Ellenberg> ;Inflammatory Bowel Diseases. 2008 Dec 1
• Omega-3 fatty acids for maintenance of remission of Crohn's disease.
  Aberra, F. N.> ;Gastroenterology. 2008 Aug 12
• High-grade dysplastic adenoma-like mass lesions are not an indication for colectomy in patients with ulcerative colitis.
  Wojciech Blonski, Rabi Kundu, Emma F. Furth, James D. Lewis, Faten Aberra, Gary R. Lichtenstein> ;Scandinavian Journal of Gastroenterology. 2008 Jan 1
• Is dysplasia visible during surveillance colonoscopy in patients with ulcerative colitis
  Wojciech Blonski, Rabi Kundu, James D. Lewis, Faten Aberra, Mark T. Osterman, Gary R. Lichtenstein> ;Scandinavian Journal of Gastroenterology. 2008 Jan 1
• Risk for Active Tuberculosis in Inflammatory Bowel Disease Patients
  Faten Aberra, Nicolas Stettler, Colleen M. Brensinger, Gary R. Lichtenstein, James D. Lewis> ;Clinical Gastroenterology and Hepatology. 2007 Sep 1
• Infliximab in ulcerative colitis.
  Faten Aberra, Gary R. Lichtenstein> ;Gastroenterology Clinics of North America. 2006 Dec 1
• Utility of the Nonabsorbed (<0.4%) Antibiotic Rifaximin in Gastroenterology and Hepatology.
  Chinyu G. Su, Faten Aberra, Gary R. Lichtenstein> ;Gastroenterología y Hepatología. 2006 Mar 1
• Join now to see all